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Abstract
We propose an integrative approach that combines structural magnetic resonance imaging
data (MRI), diffusion tensor imaging data (DTI), neuropsychological data, and genetic data to
predict early-onset obsessive compulsive disorder (OCD) severity. From a cohort of 87
patients, 56 with complete information were used in the present analysis. First, we performed
a multivariate genetic association analysis of OCD severity with 266 genetic polymorphisms.
This association analysis was used to select and prioritize the SNPs that would be included in
the model. Second, we split the sample into a training set (N = 38) and a validation set (N =
18). Third, entropy-based measures of information gain were used for feature selection with
the training subset. Fourth, the selected features were fed into two supervised methods of
class prediction based onmachine learning, using the leave-one-out procedure with the train-
ing set. Finally, the resulting model was validated with the validation set. Nine variables were
used for the creation of the OCD severity predictor, including six genetic polymorphisms and
three variables from the neuropsychological data. The developed model classified child and
adolescent patients with OCD by disease severity with an accuracy of 0.90 in the testing set
and 0.70 in the validation sample. Above its clinical applicability, the combination of particular
neuropsychological, neuroimaging, and genetic characteristics could enhance our under-
standing of the neurobiological basis of the disorder.
Introduction
Several analytical approaches have been used to predict treatment response in obsessive-com-
pulsive disorder (OCD). These approaches, designed to distinguish treatment responders from
non-responders prospectively, have used clinical, neuropsychological [1], and neuroimaging
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data [2]. These variables have been analyzed using multivariate pattern recognition approaches
from the field of machine learning, such us support vector machine (SVM), artificial neural
Networks (ANN), or naïve Bayes (NB). These methods, in comparison to univariate
approaches, allow inferences at the individual rather than the group level, thereby providing
greater clinical applicability. Machine-learning approaches have several benefits over other
multivariate pattern analysis techniques, such as logistic regression. For example, they require
fewer variables to achieve better estimates, they perform better when high-correlation struc-
tures are observed in the data, they do not need correction for multiple comparison, and they
can detect predictive variables in the absence of main effects [3].
Although machine learning has some advantages over classical statistics, it has also some
limitations that need to be considered when applying such methods to real world data [4].
Firstly, most of the algorithms used in machine learning are “black boxes” which may difficult
the interpretation of causality relationships. Second, machine learning algorithms are prone to
overfitting. Thirdly, genetic heterogeneity, one of the most important limitations in genetic
association studies, compromises the statistical power of machine learning. Fourth, several
algorithms have been developed for different machine learning methods, and there is not a
standardization of the procedures. Finally, independent replication samples are needed in
order to validate the predictive properties of these models.
Given the diagnostic limitations in the management of OCD, the heterogeneity of the dis-
ease, and the variability in response to pharmacological treatments, it is necessary to evaluate if
additional characteristics could be considered endophenotypes of treatment response. These
endophenotypes, such as the combination of particular neuropsychological, neuroimaging,
and genetic characteristics, could enhance our understanding of the neurobiological basis of
the disorder.
In this study, we propose an integrative approach that combines structural magnetic reso-
nance imaging (MRI) data [5], diffusion tensor imaging (DTI) data [6], neuropsychological data
[7], and genetic data [8] with methodologies based on high-dimensional multivariate statistical
approaches (i.e., SVM and NB) to predict OCD severity. This approach has not been applied in
this field previously, although it has provided interesting results in other diseases [9, 10].
Material and Methods
Participants
We used a previously described sample of patients with early onset OCD in this retrospective
observational study. The cohort comprised 87 patients meeting the DSM-IV [11] diagnostic
criteria for OCD recruited from the Department of Child and Adolescent Psychiatry and Psy-
chology at the Hospital Clínic, Barcelona [8]. The age of onset was defined as the age at which
patients first displayed significant distress or impairment associated with obsessive-compulsive
symptoms. Non-Caucasian patients were also excluded (N = 3). Ethnicity was determined by
self-reported ancestries to the level of their grandparents, and excluded those with non-Euro-
pean grandparents. All procedures were approved by the hospital’s ethics committee (Comité
Ético de Experimentación del Hospital Clinic de Barcelona). Written informed consent was
obtained from all parents and verbal informed consent was given by all participants following
an explanation of the procedures involved.
From the cohort of 87 patients, the following data were available: structural MRI and DTI
neuroimaging data for 62 and 63 patients, respectively [5, 6]; neuropsychological data for 72
patients [7]; and genetic data for 86 patients [8]. Complete descriptions of each population
have previously been reported. We used the data for 56 patients with complete neuroimaging,
neuropsychological, and genetic data for the development of the predictor.
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Clinical Assessment
Patients were interviewed with the Spanish version [12] of the semi-structured diagnostic inter-
view K-SADS-PL (Schedule for Affective Disorders and Schizophrenia for School-Age Chil-
dren-Present and Lifetime Version) to assess current and past psychopathology. OCD
symptoms were assessed by the Children's Yale–Brown Obsessive-Compulsive Scale
(CY-BOCS) [13]. This provides a total severity score ranging from 0 to 40, with a higher score
indicating greater severity. Depressive symptomatology was assessed with the Children's
Depression Inventory (CDI) [14]. Symptoms of anxiety were assessed by the Screen for Child-
hood Anxiety Related Emotional Disorders (SCARED) tool [15]. For the purposes of this
study, patients were categorized according to OCD severity as follows: “Mild–moderate OCD”
(CY-BOCS< 24) and “Severe–Extreme OCD” (CY-BOCS 24).
Neuropsychological, Neuroimaging and Genetic Data
A complete description of the neuroimaging assessments (including structural MRI and DTI),
neuropsychological assessments (including Wechsler Intelligence Scale, Wechsler Memory
Scale, Verbal Fluency Test, Trail Making Test, Rey Complex Figure Test, and the Stroop Test),
and genetic assessments (including rationale of candidate genes selection, single nucleotide
polymorphism [SNP] selection criteria, genotyping methodology, and quality control) can be
obtained from previous work [5–8]. S1 Table summarizes the descriptive characteristics of the
neuroimaging and neuropsychological data, and each distribution according to dichotomous
Mild–Moderate OCD and Severe–Extreme OCD categories.
Predictive Model Development
The data analysis workflow is summarized in Fig 1. The following steps were used:
1. Original Data. Genetic, neuroimaging, and neuropsychological data were available for
86, 62, and 72 patients, respectively.
2. Data preprocessing and Reduction. This was assessed in each dataset with the whole
sample. We performed a multivariate genetic association analysis of OCD severity as a dichoto-
mous variable (Mild–Moderate vs Severe–Extreme) with the 266 included SNPs, based on mul-
tiple logistic regression analysis. For this purpose, we used the SNPassoc R package [16].
Hardy–Weinberg equilibrium and linkage disequilibrium relationships between polymor-
phisms and haplotype block structures were evaluated by Haploview software v.3.2 (http://
broad.mit.edu/mpg/haploview). S1 Fig showed the results of the genetic association analysis of
OCD severity. For each of the 35 candidate genes, the SNPs with the smallest p-value (even if
non-significant) per haplotype block were selected for further analysis. Finally, 52 SNPs were
selected for further analysis (S2 Table).
3. Variable selection. The initial sample was randomly divided into a Training Set
(N = 38) and a Validation Set (N = 18). Feature selection methods were applied first, using
only the Training set, in order to select discriminative features. Entropy-based measures of
information gain (IG) were used for feature selection [17, 18]. Entropy is a measurement of the
uncertainty of a random variable, or a measurement of the dispersion (e.g., the variance). Some
authors have provided a metric for determining the gain of information for a class variable (i.e.
case/control status) [19]. This metric measures the percentage of entropy removed in the class
variable. The entropy function is a nonlinear transformation of the variables of interest, and is
commonly used in information theory to measure the uncertainty of random variables. The
algorithms for entropy-based measures of IG are implemented in a free open-source machine-
learning software package (http://orange.biolab.si/download/) [20].
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4. Predictor Creation and Validation. Features with an IG> 1 were fed into two super-
vised methods of class prediction based on machine learning (SVM and NB). Thus, data were
trained to identify classification patterns of “Mild-Moderate OCD” and “Severe-Extreme
OCD,” using the Training Set subsample. In this process, the software has all the data available
for each individual in the study, including their status as either Mild–moderate OCD or
Severe–Extreme OCD. The algorithm created by this approach is then validated with the Vali-
dation Set subsample. For this validation, the software is blinded to the dichotomous severity
status, and is used to predict severity. Multiple classification algorithms were developed using
the Orange software package, version 2.7 (http://orange.biolab.si/download/) [20]. For each
algorithm, we used the leave-one-out (LOO) procedure to correct overfitting. The best model
is selected and then additionally validated using the Validation Set subgroup randomly split in
the previous step (N = 18, see above). We evaluated the performance of the different classifica-
tion techniques using: (1) area under the receiver operating characteristic curve (AUC) analy-
ses.; (2) sensitivity (true Positives/ true positives + false negatives; i.e., a measure of the ability
of the classifier to predict “Severe-Extreme OCD correctly); (3) specificity (true negative/true
negative + false negative; i.e., a measure of the capacity to reject “Mild-Moderate OCD cor-
rectly); (4) accuracy (true positive + true negative/all; i.e., a measure of the capacity to predict
Fig 1. The data analysis workflow used in the present study.OCD, obsessive-compulsive disorder; MRI, magnetic resonance imaging; DTI, diffusion
tensor imaging; SNP, single nucleotide polymorphism; CV, cross-validation.
doi:10.1371/journal.pone.0153846.g001
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both “Severe-Extreme OCD and “Mild-Moderate OCD correctly); (5) Precision (true positive/
true positive + false positive; i.e., a measure of the ability to predicted “Severe-Extreme OCD
correctly). We used the SVM and NB machine learning methods [21, 22]. Each classifier was
validated using 10-fold cross-validation. Briefly:
• Radial basis function (RBF) kernels (Gaussian SVM) were used in this study. The RBF kernel
is a function that transforms attribute space to a new feature space to fit the maximum-mar-
gin hyperplane, allowing the algorithm to create nonlinear classifiers. We used the Automatic
Parameter Search that tunes the relevant SVM parameters in a methodologically sound man-
ner. On each fold of cross-validation for evaluation, the Automatic Parameter Search uses an
internal cross-validation run, using only the training data for the current evaluation fold.
This finds the optimal parameter settings based on the training data alone. All other parame-
ters were set to default.
• NB is a Bayesian Networks method that treats features in the data as random variables and
represents them as nodes in a directed acyclic graph. Connected nodes are considered
“parents.” In NB, each attribute node is assigned exactly one parent node, assuming that all
risk factors are conditionally independent given the outcome of interest. The method used
for estimating prior class probabilities from the data was the Laplace estimate. The method
for estimating conditional probabilities was the m-estimate (parameter was set to 2.0).
Because the class was binary, the classification accuracy could be increased considerably by
letting the learner find the optimal classification threshold. The threshold was computed
from the training data.
To provide a statistical significance of the results of each classifier and to determine if our
results occurred by chance, we also conducted a random permutation test for each classifier.
That is, we conducted 1000 random trials in which each trial consisted of the following: (a) ran-
dom permutation of the labels of the data (case/control) so that the labels no longer match the
real data in any meaningful way; (b) running the classifier algorithm on the data with these
random labels; (c) assessing their predictive performance; and (d) applying the statistical test to
compare against the predictive performance obtained for the original data. Permutations were
run using specific R packages.
Statistical analysis
Statistical analyses were performed in SPSS version 17 (SPSS inc, Chicago, Ill). Normal distri-
butions of the data were confirmed using Shapiro-Wilk test, and equality of the variance
between groups was assessed by means of Levene’s test. For comparing two groups, a two-tailed
Student’s t test was used. Significance was set at P< 0.05.
Results
Table 1 summarizes the demographic, clinical, and pharmacological information of the 56
patients with early onset OCD included for the creation and validation of the OCD severity
predictor. Significant differences were observed in the pharmacological treatment, revealing
that patients with Severe-Extreme OCD in comparison to the patients with Mild-Moderate
OCD tended to be treated with adjuvant antipsychotic therapy (26.31% vs 0.00%, X21 = 5.766,
p = 0.016) and clomipramine (alone or in combination with fluoxetine), although the differ-
ence was not statistically significant (32.34% vs 7.14%, X21 = 3.36 p = 0.0667).
Entropy-based measures of IG were used for feature selection. Table 2 summarizes the nine
variables with an IG value> 1 used for the creation of the OCD severity predictor. As observed,
six of the nine variables were genetic, including rs2247215 (GRIK2), rs4887348 (NTRK3),
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rs11583978 (DLGAP3), rs7858819 (SLC1A1), rs27072 (SLC6A3) and rs548294 (GRIA1). Three
non-genetic variables from the neuropsychological dataset were included in the model. These
variables were related to the following domains: visuospatial ability (WISC_Block, Wechsler
Table 1. Demographic, clinical, and pharmacological information of the patients with early onset OCD and complete data included in the creation
and validation of the OCD severity predictor.
Severity
Mild-Moderate Severe-Extreme Total Statistic, p-value
N 18 38 56
Sex (M/F) 8/10 25/13 33/23 X21 = 2.29, p = 0.129
Age (mean ± SD) 16.14 ± 2.45 15.46 ± 1.81 15.68 ± 2.04 t54 = -1.171, p = 0.247
Age at 1st symptom (mean ± SD) 10.76 ± 3.88 9.53 ± 3.61 9.91 ± 3.70 t54 = 1.148, p = 0.256
Age at Onset (mean ± SD) 13.58 ± 3.04 12.90 ± 2.32 13.12 ± 2.56 t54 = 0.917, p = 0.363
Evolution (months) (mean ± SD) 27.83 ± 24.23 29.63 ± 25.54 29.05 ± 24.92 t54 = -0.263, p = 0.794
Dimensions N (%)
Washing/cleaning 3 (16.66) 8 (21.05) 11 (19.64) X21 = 0.148, p = 0.699
Harm/Checking 11 (61.11) 24 (63.15) 35 (62.50) X21 = 0.021, p = 0.882
Symmetry/ordering 4 (22.22) 6 (15.79) 10 (17.85) X21 = 0.344, p = 0.557
Course of the disease
Continuous 8 (44.44) 28 (73.68) 36 (64.28) X21 = 4.548, p = 0.032
Episodic 10 (55.55) 10 (26.31) 20 (35.71) X21 = 4.548, p = 0.032
Comorbidities N (%)
None 7 (38.88) 17 (44.73) 24 (42.85) X21 = 0.170, p = 0.679
ADHD 2 (11.11) 6 (15.78) 8 (14.28) X21 = 0.218, p = 0.640
Anxiety disorder 4 (22.22) 11 (28.94) 15 (26.78) X21 = 0.281, p = 0.595
Tics 3 (16.66) 2 (5.26) 5 (8.92) X21 = 1.953, p = 0.162
Eating disorder 2 (11.11) 2 (5.26) 4 (7.14) X21 = 0.629, p = 0.427
Family history of OCD N (%)1
None 10 (58.82) 20 (62.50) 30 (61.22) X21 = 0.063, p = 0.801
First grade 7 (41.17) 8 (25.00) 15 (38.46) X21 = 1.637, p = 0.242
Second grade 0 (0.00) 4 (12.50) 4 (8.51) X21 = 2.313, p = 0.128
Current CY-BOCS (mean ± SD) 12.67 ± 4.93 20.95 ± 8.09 18.29 ± 8.17 t54 = -3.991, p < 0.001
Maxim CY-BOCS (mean ± SD) 19.33 ± 2.08 30.97 ± 5.03 27.23 ± 6.96 t54 = -9.402, p < 0.001
SCARED (mean ± SD) 22.35 ± 13.53 29.97 ± 13.91 27.43 ± 14.12 t54 = -1.859, p = 0.069
CDI (mean ± SD) 11.22 ± 11.01 15.18 ± 8.82 13.81 ± 9.72 t54 = -1.409, p = 0.165
Treatment N (%)
None 4 (22.22) 4 (10.53) 8 (14.28) X21 = 1.364, p = 0.242
Antidepressant 14 (77.77) 24 (63.15) 38 (67.85) X21 = 1.196, p = 0.273
Antidepressant + Antipsychotic 0 (0.00) 10 (26.31) 10 (17.85) X21 = 5.766, p = 0.016
Type of Antidepressant N (%)
Fluoxetine 6 (42.85) 14 (41.18) 20 (41.66) X21 = 0.011, p = 0.914
Fluvoxamine 3 (21.43) 4 (11.76) 7 (14.58) X21 = 0.743, p = 0.388
Sertraline 4 (28.57) 5 (14.70) 9 (18.75) X21 = 1.251, p = 0.263
Clomipramine 1 (7.14) 8 (23.52) 9 (18.75) X21 = 1.747, p = 0.186
Fluoxetine + Clomipramine 0 (0.00) 3 (8.82) 3 (6.25) X21 = 1.317, p = 0.251
1No information provided by seven participants
CDI, the Children's Depression Inventory; CY-BOCS, Children's Yale–Brown Obsessive-Compulsive Scale; OCD, obsessive-compulsive disorder;
SCARED, Screen for Childhood Anxiety Related Emotional Disorders.
doi:10.1371/journal.pone.0153846.t001
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Intelligence Scale for Children IV Block design), non-verbal memory (RCFT_immediate, Rey
Complex Figure Test Immediate Recall) and working memory (WISC_Digit, Wechsler Intelli-
gence Scale for Children IV Digit Span). Finally, none of the variables from the neuroimaging
datasets (MRI and DTI) exceeded the information gain threshold and so none were included in
the model.
Table 3 summarizes the results of applying the selected variables when developing of the
predictor using SVM and NB classifiers. As expected, both methods provided perfect predic-
tions in the training samples when applying the LOO procedure. In this regard, testing sample
predictions became significant after permutation corrections for multiple testing, although
SVM presented better statistics than NB. When the validation sample was used, identical
results were obtained when applying either the SVM or the NB machine-learning method.
Discussion
In the present study, we found that the multivariate statistical tools SVM and NB could be
helpful in the search for predictors of diagnostic outcomes in patients with early onset OCD.
Table 2. Variables selected for the creation of the OCD severity predictor. Only variables with an Information gain > 0.1 are included.
Genetic Variables Selected
Rank Order SNP Information Gain1 Gene Symbol Chromosome2 Chromosome Position2 p-value3
1 rs2247215 0.228 GRIK2 6 101966354 0.08482
2 rs4887348 0.217 NTRK3 15 88571434 0.03553
4 rs11583978 0.181 DLGAP3 1 35330422 0.78668
5 rs7858819 0.180 SLC1A1 9 4559792 0.70404
8 rs27072 0.145 SLC6A3 5 1394422 0.03084
9 rs548294 0.121 GRIA1 5 152868337 0.06734
Non-Genetic Variables Selected
Rank Order Variable Information Gain1 Data Type p-value4
3 WISC_Block 0.201 Neuropsychological Dataset 0.856
6 WISC_Digit 0.157 Neuropsychological Dataset 0.421
7 RCFT_immediate 0.157 Neuropsychological Dataset 0.039
1Calculated as described in Material and Methods
2Chromosome and position according to NCBI Homo sapiens Annotation Release 105 (assembly GRCh37.p13)
3p-values obtained in the genetic association study as described in Material and Methods, signiﬁcant p-value after Bonferroni correction p < 1 × 10−4
4p-value of the t-test “Moderate OCD” vs “Severe OCD”
WISC_Block, Wechsler Intelligence Scale for Children IV Block design; WISC_Digit, Wechsler Intelligence Scale for Children IV Digit Span;
RCFT_immediate, Rey Complex Figure Test Immediate Recall
doi:10.1371/journal.pone.0153846.t002
Table 3. Summary of the performances estimates of the two developedmachine-learningmethods. This table summarizes the performances esti-
mates of the two machine-learning methods used in the present study (support vector machine [SVM] and naïve Bayes [NB]) developed with the training sam-
ple and validated with the validation sample. For each machine-learning method we show: (1) the estimates of the training step using the LOO procedure;
and (2) the estimates obtained with the Validation Set subsample. P-values were obtained after 10.000 permutation cycles as described in the Material and
Methods section (**p < 0.01; *p < 0.05).
Machine-Learning Method Sample Accuracy Sensibility Speciﬁcity Precision AUC
Support Vector Machine LOO 0.96 ** 0.94 ** 1.00 ** 0.95 ** 0.98 **
Validation 0.69 0.71 0.67 0.63 0.75
Naïve Bayes LOO 0.94 * 0.87 * 0.89 ** 0.87 ** 0.88 *
Validation 0.65 0.81 0.50 0.75 0.77
doi:10.1371/journal.pone.0153846.t003
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By integrating neuroimaging, neuropsychological and genetic data sources, we designed an
analysis pathway with variables that had the highest predictive value. This allowed us to
develop a model that classified child and adolescent patients with OCD by disease severity with
an accuracy of 0.90.
To our knowledge, this is the first study to use a machine-learning model as a multivariate
statistical tool to integrate variables from different sources that might predict the diagnosis of
early onset OCD. Despite the increasing application of machine-learning methods in psychia-
try to predict disease diagnoses [3], their application in OCD has been limited. In OCD,
machine learning has mainly been used to investigate potential biomarkers for disease diagno-
sis using neuroimaging data from structural MRI [23] or DTI [24] as the single source. Struc-
tural MRI data have also been used to predict OCD severity in combination with support
vector regression methods [2], as have clinical and neuropsychological data using the ANN
model to predict OCD treatment outcomes [1]. However, no studies have previously used
either different data sources or included genetic data to predict OCD or disease severity.
In our model, we used genetic and neuropsychological data as predictive variables of OCD
severity. For the genetic variables, we included six SNPs in genes related to glutamate (GRIK2,
GRIA1, DLAGAP3 and SLC1A1) and dopamine neurotransmission (SLC6A3) and genes
involved in neurodevelopment (NTRK3). Some of these genes had previously been related to
OCD or OCD symptom severity. Glutamate and dopamine, jointly with serotonin, are the
main neurotransmitters involved in the cortical-striatal-thalamo-cortical (CSTC) circuit. Dys-
function in the CSTC circuit has been postulated in the etiology of OCD and a growing body of
evidence has suggested that the neurotransmission of glutamate, a major neurotransmitter in
the CSTC circuit, is disrupted in OCD [25]. On this regard, candidate gene studies have identi-
fied associations between variants in glutamate system genes and OCD. Our OCD severity
model includes SLC1A1, which codes for the neuronal glutamate transporter excitatory amino
acid carrier 1 and is one of the best-supported candidate genes for OCD. The gene was identi-
fied in two independent genome-wide linkage studies, and a recent meta-analysis revealed a
weak association between OCD and one SLC1A1 polymorphism [26]. Animal models of OCD
also support the involvement of glutamate dysfunctions. Knock-out mice for DLGAP3, a scaf-
folding protein involved in vesicle trafficking in glutamatergic neurons, displayed OCD-like
behavior consisting of compulsive grooming and anxiety-like phenotypes [27]. Genetic poly-
morphisms in two glutamate receptors, GRIK2 and GRIA1, were also included in the model.
GRIK2 has been identified in a recent genome wide association study of OCD [28]. Other ani-
mal studies have shown, in GRIK2 deficient mice, a significant reduction in fear memory and
less anxious behaviors compared to wild type mice. [29, 30]. GRIA1, the other glutamate recep-
tor identified in our study, has been associated with total choline level in our cohort [31]. Cho-
line-containing compounds are components of cell membranes. The occasional findings of
increased choline in OCDmight indicate myelin breakdown [32]. This interpretation is
strengthened by findings of WM abnormalities in OCD patients [5, 6]. Several findings demon-
strate that WM and GM structure in OCD alters severity as a function of symptoms [33–36].
However, the picture of widespread structural alterations may partially result from the complex
phenomenology of OCD and its specific underlying neurobiology [37]. Interestingly, one of
the neurodevelopment genes of the model, NGFR, has been associated with these WMmicro-
structures in our population [38], specifically in the left and right anterior and posterior cere-
bellum. Furthermore, the natural ligand of NGFR, BDNF, had previously been associated with
OCD severity [39], and its interaction with a dopamine gene, COMT, had been associated with
OCD [40].
Dopamine genes are classical candidate genes of genetic association studies of OCD.
Although controversial results were obtained for most of these genes, a recent meta-analysis
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identified significant associations between COMT polymorphisms and OCD (only in males)
and a non-significant trend for SLC6A3 variants [41].
The neuropsychological variables included in our model accounted for several domains
such as visuospatial ability, non-verbal memory, and working memory. Although results from
neuropsychological studies are heterogeneous [42, 43], in general the findings support the
notion that patients with OCD show visuospatial ability and non-verbal memory [44].
Studies looking at the relation between neuropsychological dysfunction and symptom sever-
ity have provided inconsistent results [45]. In our study, no individual neuropsychological vari-
able showed significant differences by OCD severity, yet in combination with genetic and
neuroimaging variables were able to identify patients with severe OCD. These results appear to
be consistent with the neuropsychobiological hypotheses of OCD [43]. These hypotheses are
based on an integrative model of genetics, environment and neurobiology data for the expres-
sion of OCD with several steps: (1) individuals with OCDmay be genetically vulnerable to
environmental factors that may induce modification of the glutamate-, serotonin- and dopa-
mine-systems. Our integrative severity model of OCD includes variants in genes related to
dopamine and glutamate neurotransmission. These genetic polymorphisms are not directly
related to the risk of the disease, but rather could increase the level of alteration of these neuro-
transmitters in the presence of gene-environment interactions, increasing the severity of the
disease. (2) The modification of the neurotransmission could result in an imbalance of the
CSTC circuit. Our model also included genes that participate in the CSTSC loops. Once again,
the presence of these genetic variants could increase the effects of gene-environment interac-
tions in the CSTSC circuit explaining its association with WM abnormalities. (3) That imbal-
ance of the CSTC circuit is associated with the phenotypic presentation of OCD
phenomenology. The neuropsychological components of our model accounted for executive
functioning and verbal and non-verbal functions could both play a role in the worsening of
symptoms. In summary different brain alterations could lead to neuropsychological character-
istics of OCD that could be translated to differences in OCD symptoms and severity. These dif-
ferences, in turn, could be due to the involvement of different brain circuits. This complexity
may be difficult to detect by traditional statistics, but were identifiable by machine-learning
multivariate statistical tools (i.e., SVM and NB).
The findings from this study should be interpreted in the context of important limitations.
The study’s primary limitation was that the majority of patients with OCD were medicated and
symptomatically stable when they underwent neuroimaging. Although we found no evidence
for a significant impact of medication, it is possible that antidepressant or antipsychotic expo-
sure contributed to the outcomes, potentially confounding any inference that can be drawn.
Another important limitation is the sample size used, which limits the statistical power of the
study and makes it difficult to detect small or modest effects of common variants. Given that
the study was hypothesis-driven, and due to the small sample size, our results should be seen as
preliminary and should be considered as exploratory findings in need of further confirmation.
However, it should be noted that our sample comprised early-onset OCD patients, and so the
sample represented a homogeneous clinical population. In addition, during construction of the
dataset, several participants were excluded (e.g. those who had not undergone neuroimaging)
which could have led to the exclusion of the most acutely or severely ill and least cooperative
patients. However, the included patients did not differ significantly from those excluded in
terms of demographic data or symptom severity. Next, the sample sizes of the Moderate
(N = 18) and Severe (N = 38) OCD groups were different, which may have artificially increased
the accuracy of the Severe vs Moderate OCD classifier due to a bias toward the sensitivity esti-
mate. Finally, this was a single-center study, which precludes generalization to different
research centers with different populations.
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The evidence presented suggests that patients with severe forms of early onset OCD could
be identified using a range of genetic and neuropsychological data. From a clinical perspective,
the results provide preliminary support for the translational development of machine-learning
predictors as a clinically useful diagnostic tool. However, the economical costs and complexity
of acquiring genetic data in comparison to severity scales, like CYBOCS, make it difficult for its
clinical translation. Above its clinical applicability, the combination of particular neuropsycho-
logical, neuroimaging, and genetic characteristics could enhance our understanding of the
neurobiological basis of the disorder.
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